GlassScriptPhysician profile
Andrew C Catalone
NPI 1871698498
$26,072.94
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $26K · 2022: $174.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $15,530.37 | 2021-2022 | |
| Abbvie INC. | $8,422.65 | 2021 | |
| Allergan, INC. | $825.00 | 2021 | |
| Alkermes, INC. | $364.73 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $329.54 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $320.52 | 2021-2022 | |
| Neurocrine Biosciences, INC. | $91.91 | 2021 | |
| Vanda Pharmaceuticals INC. | $74.20 | 2021 | |
| Janssen Pharmaceuticals, INC | $45.83 | 2021 | |
| Indivior INC. | $22.95 | 2021 | |
| Almatica Pharma LLC | $17.85 | 2021 | |
| Supernus Pharmaceuticals, INC. | $14.08 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $13.31 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Catalone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.